Review





Similar Products

86
Magen Biotechnology Co Ltd qrt pcr analysis hipure hp plant rna mini kit
Qrt Pcr Analysis Hipure Hp Plant Rna Mini Kit, supplied by Magen Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qrt-pcr+analysis/pm42310892-82-3-11?v=Magen+Biotechnology+Co+Ltd
Average 86 stars, based on 1 article reviews
qrt pcr analysis hipure hp plant rna mini kit - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Xinbei Jiang Pharmaceutical Co Ltd qrt pcr analysis
Qrt Pcr Analysis, supplied by Xinbei Jiang Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qrt-pcr+analysis/pm41722769-96-10-12?v=Xinbei+Jiang+Pharmaceutical+Co+Ltd
Average 86 stars, based on 1 article reviews
qrt pcr analysis - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

98
Toyobo qrt pcr analysis
Qrt Pcr Analysis, supplied by Toyobo, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qrt-pcr+analysis/pmc12815260-161-26-37?v=Toyobo
Average 98 stars, based on 1 article reviews
qrt pcr analysis - by Bioz Stars, 2026-08
98/100 stars
  Buy from Supplier

86
Human Protein Atlas qrt pcr analysis
MIR4435-2HG is upregulated in HCC, predicts poor prognosis, and promotes malignant phenotypes ( A ) Analysis of the TCGA-LIHC dataset shows significant upregulation of MIR4435-2HG in HCC tissues compared to adjacent non-tumor tissues. ( B ) Kaplan-Meier analysis of overall survival in HCC patients stratified by MIR4435-2HG expression using the median cutoff (50th percentile, n = 182 per group). ( C <t>)</t> <t>qRT-PCR</t> analysis confirms high expression of MIR4435-2HG in a panel of HCC cell lines. ( D ) CCK-8 assays in PLC/PRF5 and Huh7 cells demonstrate that knockdown of MIR4435-2HG suppresses proliferation, while its overexpression enhances proliferation. ( E ) The half-maximal inhibitory concentration (IC₅₀) of lenvatinib in parental and resistant PLC/PRF5 and Huh7 cells. ( F ) MIR4435-2HG expression is further elevated in acquired lenvatinib-resistant HCC cells (Huh7-L-R, PLC/PRF5-L-R) compared to their parental counterparts. ( G ) Transwell migration and invasion assays show that knockdown of MIR4435-2HG reduces, while its overexpression enhances, migratory and invasive capabilities in lenvatinib-resistant PLC/PRF5 and Huh7 cells. Data are presented as mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Qrt Pcr Analysis, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qrt-pcr+analysis/pmc12849258-144-64-25?v=Human+Protein+Atlas
Average 86 stars, based on 1 article reviews
qrt pcr analysis - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Solexa rna isolation solexa sequencing in silico analysis qrt pcr statistical analysis
MIR4435-2HG is upregulated in HCC, predicts poor prognosis, and promotes malignant phenotypes ( A ) Analysis of the TCGA-LIHC dataset shows significant upregulation of MIR4435-2HG in HCC tissues compared to adjacent non-tumor tissues. ( B ) Kaplan-Meier analysis of overall survival in HCC patients stratified by MIR4435-2HG expression using the median cutoff (50th percentile, n = 182 per group). ( C <t>)</t> <t>qRT-PCR</t> analysis confirms high expression of MIR4435-2HG in a panel of HCC cell lines. ( D ) CCK-8 assays in PLC/PRF5 and Huh7 cells demonstrate that knockdown of MIR4435-2HG suppresses proliferation, while its overexpression enhances proliferation. ( E ) The half-maximal inhibitory concentration (IC₅₀) of lenvatinib in parental and resistant PLC/PRF5 and Huh7 cells. ( F ) MIR4435-2HG expression is further elevated in acquired lenvatinib-resistant HCC cells (Huh7-L-R, PLC/PRF5-L-R) compared to their parental counterparts. ( G ) Transwell migration and invasion assays show that knockdown of MIR4435-2HG reduces, while its overexpression enhances, migratory and invasive capabilities in lenvatinib-resistant PLC/PRF5 and Huh7 cells. Data are presented as mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Rna Isolation Solexa Sequencing In Silico Analysis Qrt Pcr Statistical Analysis, supplied by Solexa, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qrt-pcr+analysis/pmc12733558-15-42-44?v=Solexa
Average 86 stars, based on 1 article reviews
rna isolation solexa sequencing in silico analysis qrt pcr statistical analysis - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Exosome Diagnostics isolation exosome characterization electron microscopy rna processing mirna profiling mirna target prediction pathway analysis taqman mirna assay qrt pcr statistical analysis
MIR4435-2HG is upregulated in HCC, predicts poor prognosis, and promotes malignant phenotypes ( A ) Analysis of the TCGA-LIHC dataset shows significant upregulation of MIR4435-2HG in HCC tissues compared to adjacent non-tumor tissues. ( B ) Kaplan-Meier analysis of overall survival in HCC patients stratified by MIR4435-2HG expression using the median cutoff (50th percentile, n = 182 per group). ( C <t>)</t> <t>qRT-PCR</t> analysis confirms high expression of MIR4435-2HG in a panel of HCC cell lines. ( D ) CCK-8 assays in PLC/PRF5 and Huh7 cells demonstrate that knockdown of MIR4435-2HG suppresses proliferation, while its overexpression enhances proliferation. ( E ) The half-maximal inhibitory concentration (IC₅₀) of lenvatinib in parental and resistant PLC/PRF5 and Huh7 cells. ( F ) MIR4435-2HG expression is further elevated in acquired lenvatinib-resistant HCC cells (Huh7-L-R, PLC/PRF5-L-R) compared to their parental counterparts. ( G ) Transwell migration and invasion assays show that knockdown of MIR4435-2HG reduces, while its overexpression enhances, migratory and invasive capabilities in lenvatinib-resistant PLC/PRF5 and Huh7 cells. Data are presented as mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Isolation Exosome Characterization Electron Microscopy Rna Processing Mirna Profiling Mirna Target Prediction Pathway Analysis Taqman Mirna Assay Qrt Pcr Statistical Analysis, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qrt-pcr+analysis/pmc12733558-43-92-93?v=Exosome+Diagnostics
Average 86 stars, based on 1 article reviews
isolation exosome characterization electron microscopy rna processing mirna profiling mirna target prediction pathway analysis taqman mirna assay qrt pcr statistical analysis - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

99
TaKaRa qrt pcr analysis
MIR4435-2HG is upregulated in HCC, predicts poor prognosis, and promotes malignant phenotypes ( A ) Analysis of the TCGA-LIHC dataset shows significant upregulation of MIR4435-2HG in HCC tissues compared to adjacent non-tumor tissues. ( B ) Kaplan-Meier analysis of overall survival in HCC patients stratified by MIR4435-2HG expression using the median cutoff (50th percentile, n = 182 per group). ( C <t>)</t> <t>qRT-PCR</t> analysis confirms high expression of MIR4435-2HG in a panel of HCC cell lines. ( D ) CCK-8 assays in PLC/PRF5 and Huh7 cells demonstrate that knockdown of MIR4435-2HG suppresses proliferation, while its overexpression enhances proliferation. ( E ) The half-maximal inhibitory concentration (IC₅₀) of lenvatinib in parental and resistant PLC/PRF5 and Huh7 cells. ( F ) MIR4435-2HG expression is further elevated in acquired lenvatinib-resistant HCC cells (Huh7-L-R, PLC/PRF5-L-R) compared to their parental counterparts. ( G ) Transwell migration and invasion assays show that knockdown of MIR4435-2HG reduces, while its overexpression enhances, migratory and invasive capabilities in lenvatinib-resistant PLC/PRF5 and Huh7 cells. Data are presented as mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Qrt Pcr Analysis, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qrt-pcr+analysis/pm41366770-209-5-15?v=TaKaRa
Average 99 stars, based on 1 article reviews
qrt pcr analysis - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

Image Search Results


MIR4435-2HG is upregulated in HCC, predicts poor prognosis, and promotes malignant phenotypes ( A ) Analysis of the TCGA-LIHC dataset shows significant upregulation of MIR4435-2HG in HCC tissues compared to adjacent non-tumor tissues. ( B ) Kaplan-Meier analysis of overall survival in HCC patients stratified by MIR4435-2HG expression using the median cutoff (50th percentile, n = 182 per group). ( C ) qRT-PCR analysis confirms high expression of MIR4435-2HG in a panel of HCC cell lines. ( D ) CCK-8 assays in PLC/PRF5 and Huh7 cells demonstrate that knockdown of MIR4435-2HG suppresses proliferation, while its overexpression enhances proliferation. ( E ) The half-maximal inhibitory concentration (IC₅₀) of lenvatinib in parental and resistant PLC/PRF5 and Huh7 cells. ( F ) MIR4435-2HG expression is further elevated in acquired lenvatinib-resistant HCC cells (Huh7-L-R, PLC/PRF5-L-R) compared to their parental counterparts. ( G ) Transwell migration and invasion assays show that knockdown of MIR4435-2HG reduces, while its overexpression enhances, migratory and invasive capabilities in lenvatinib-resistant PLC/PRF5 and Huh7 cells. Data are presented as mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Journal: Cancer Cell International

Article Title: Targeting the MIR4435-2HG/miR-29c-3p/FSP1 axis overcomes lenvatinib resistance by inducing ferroptosis in hepatocellular carcinoma

doi: 10.1186/s12935-025-04147-5

Figure Lengend Snippet: MIR4435-2HG is upregulated in HCC, predicts poor prognosis, and promotes malignant phenotypes ( A ) Analysis of the TCGA-LIHC dataset shows significant upregulation of MIR4435-2HG in HCC tissues compared to adjacent non-tumor tissues. ( B ) Kaplan-Meier analysis of overall survival in HCC patients stratified by MIR4435-2HG expression using the median cutoff (50th percentile, n = 182 per group). ( C ) qRT-PCR analysis confirms high expression of MIR4435-2HG in a panel of HCC cell lines. ( D ) CCK-8 assays in PLC/PRF5 and Huh7 cells demonstrate that knockdown of MIR4435-2HG suppresses proliferation, while its overexpression enhances proliferation. ( E ) The half-maximal inhibitory concentration (IC₅₀) of lenvatinib in parental and resistant PLC/PRF5 and Huh7 cells. ( F ) MIR4435-2HG expression is further elevated in acquired lenvatinib-resistant HCC cells (Huh7-L-R, PLC/PRF5-L-R) compared to their parental counterparts. ( G ) Transwell migration and invasion assays show that knockdown of MIR4435-2HG reduces, while its overexpression enhances, migratory and invasive capabilities in lenvatinib-resistant PLC/PRF5 and Huh7 cells. Data are presented as mean ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Article Snippet: Kaplan-Meier survival analysis indicates that high FSP1 expression is strongly associated with poorer overall survival in HCC patients. ( D ) Immunohistochemistry data from The Human Protein Atlas demonstrates elevated FSP1 protein expression in HCC specimens. ( E, F ) Experimental validation of FSP1 upregulation in HCC cell lines at the mRNA ( E ) and protein ( F ) levels. ( G ) qRT-PCR analysis revealed the regulatory role of MIR4435-2HG on FSP1 mRNA expression.

Techniques: Expressing, Quantitative RT-PCR, CCK-8 Assay, Knockdown, Over Expression, Concentration Assay, Migration